Recombinant human granulocyte colony-stimulating factor (Harbin Pharmaceutical Group Bioengineering)

重组人粒细胞刺激因子（哈药集团生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human granulocyte colony-stimulating factor (Harbin Pharmaceutical Group Bioengineering)
Drug Alias Name里亚金Li Ya Jin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHarbin Pharmaceutical Group Holding Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A